| 2026-03-24 |
详情>>
股本变动：
变动后总股本326.90万股
变动原因 ▼▲
- 原因：
- Ordinary Share offered 459,112 shares by the company
|
| 2026-03-19 |
详情>>
业绩披露：
2025年年报每股收益-2.19美元,归母净利润-612.7万美元,同比去年增长42.09%
|
| 2026-03-09 |
复牌提示：
2026-03-09 09:59:41 停牌，复牌日期 2026-03-09 10:04:41
|
| 2025-11-20 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.13美元,归母净利润-314万美元,同比去年增长33.67%
|
| 2025-09-25 |
股东大会：
将于2025-11-11召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the year 2025 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2024;
2.To approve the re-election of Mr. Moshe Arkin, Mr. Itai Arkin, Ms. Hanna Lerman, and Mr. Sharon Kochan, to the Board of Directors, each for an additional term until the annual general meeting to be held in 2026;
3.To approve the re-appointment of Mr. Moshe Arkin, the current interim Chief Executive Officer of the Company, Executive Chairman of the Board of Directors and the Company's controlling shareholder, to serve as the interim Chief Executive Officer of the Company for an additional term not to exceed twelve months, effective January 1, 2026, subject to and in accordance with, the provisions of the Israeli Companies Law, 5759-1999, or the Companies Law.
|
| 2025-05-23 |
详情>>
业绩披露：
2025年一季报每股收益-3.2美元,归母净利润-880.8万美元,同比去年增长-38.84%
|
| 2025-05-05 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2025-04-29 |
详情>>
业绩披露：
2024年年报每股收益-0.38美元,归母净利润-1058万美元,同比去年增长61.16%
|
| 2025-04-29 |
详情>>
业绩披露：
2022年年报每股收益-0.65美元,归母净利润-1492.3万美元,同比去年增长-563.3%
|
| 2025-02-18 |
股东大会：
将于2025-04-01召开股东大会
会议内容 ▼▲
- 1.To approve a reverse share split of the Company’s ordinary shares, NIS 0.1 par value each (“Ordinary Shares”), at a ratio within a range of 2 for 1 to 10 for 1, which final ratio is to be determined by our Board of Directors, to be effective on a date to be determined by our Board of Directors within 12 months of the Meeting, and to approve the amendment of our Articles of Association accordingly;
2.To approve the renewal of an updated version of the Compensation Policy for the Company’s officers and directors for an additional three-year period in accordance with the requirements of the Israeli Companies Law, 5759-1999, or the Companies Law.
|
| 2024-11-15 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.17美元,归母净利润-473.4万美元,同比去年增长78.87%
|
| 2024-09-25 |
股东大会：
将于2024-11-04召开股东大会
会议内容 ▼▲
- 1.To approve the appointment of Mr. Moshe Arkin, the current Executive Chairman of the Board of Directors and the Company's controlling shareholder, as the interim Chief Executive Officer of the Company, in addition to his role as Executive Chairman, for a term not to exceed twelve months, effective January 1, 2025, subject to and in accordance with, the provisions of the Israeli Companies Law, 5759-1999, or the Companies Law.
2.To approve the Company's 2024 Employees Share Option Plan.
|
| 2024-08-16 |
详情>>
业绩披露：
2024年中报每股收益-0.16美元,归母净利润-436.8万美元,同比去年增长73.83%
|
| 2024-07-15 |
股东大会：
将于2024-08-27召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company's independent auditors for the year 2024 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2023.
2.To approve the re-election of Dr. Alon Seri-Levy, Mr. Moshe Arkin, Mr. Itai Arkin, Ms. Hani Lerman, and Mr. Sharon Kochan, to the Board of Directors, each for an additional one-year term until the annual general meeting to be held in 2025.
3.To approve the separation agreement with our Chief Executive Officer Dr.Alon Seri-Levi.
|
| 2024-05-20 |
详情>>
业绩披露：
2024年一季报每股收益-0.23美元,归母净利润-634.4万美元,同比去年增长40.83%
|
| 2024-03-13 |
详情>>
业绩披露：
2023年年报每股收益-1.01美元,归母净利润-2723.8万美元,同比去年增长-82.52%
|
| 2024-01-17 |
股东大会：
将于2024-02-28召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of Mr. Ran Gottfried and election of Mr. Yuval Yanai as external directors of the Company, each for a three-year term, subject to, and in accordance with, the provisions of the Israeli Companies Law, 5759-1999, or the Companies Law;
2.To approve the cash compensation and the grant of options to purchase ordinary shares of the Company to each of our external directors and other independent directors in accordance with the requirements of the Companies Law.
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.84美元,归母净利润-2240.2万美元,同比去年增长-145.15%
|
| 2023-06-14 |
股东大会：
将于2023-07-26召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the year 2023 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2022.
2.To approve the election of Mr. Sharon Kochan and the re-election of Dr. Alon Seri-Levy, Mr. Moshe Arkin, Mr. Itai Arkin, Ms. Hani Lerman, Dr. Shmuel Ben Zvi and Mr. Jonathan B. Siegel to Board of Directors, each for an additional one-year term until the annual general meeting to be held in 2024.
3.To approve the grant of an award of options to and an amendment to the terms of engagement of Dr. Alon Seri-Levi.
4.To approve amendments to the Company’s Compensation Policy.
|
| 2023-03-01 |
股东大会：
将于2023-03-30召开股东大会
会议内容 ▼▲
- 1.To approve a private placement to M. Arkin Dermatology Ltd., the Company’s controlling shareholder.
2.To approve the renewal of the Registration Rights Agreement between the Company and M. Arkin Dermatology Ltd.
|
| 2023-02-13 |
股东大会：
将于2023-03-23召开股东大会
会议内容 ▼▲
- 1.To approve a private placement to M. Arkin Dermatology Ltd., the Company’s controlling shareholder.
2.To approve the renewal of the Registration Rights Agreement between the Company and M. Arkin Dermatology Ltd.
|
| 2022-05-12 |
股东大会：
将于2022-06-23召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the year 2022 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2021;
2.To approve an amendment to the Company's Amended and Restated Articles of Association to provide that all Company directors will be elected or re-elected every year rather than every three years;
3.To approve the re-election of Mr. Alon Seri-Levy, Mr. Moshe Arkin, Mr. Itai Arkin, Ms. Hani Lerman, Mr. Shmuel Ben Zvi, Ms. Yaffa Krindel-Sieradzki, Mr. Jonathan B. Siegel, Mr. Ran Gottfried and Mr. Jerrold S. Gattegno to the board of directors of the Company, each for an additional one-year term until the annual general meeting to be held in 2023;
4.To approve the annual cash bonus plan for 2022 for Dr. Alon Seri-Levy, the Company's chief executive officer;
5.To approve an amended Compensation Policy for a period of three years.
|
| 2022-04-08 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the year 2022 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2021;
2.To approve an amendment to the Company's Amended and Restated Articles of Association to provide that all Company directors will be elected or re-elected every year rather than every three years;
3.To approve the re-election of Mr. Alon Seri-Levy, Mr. Moshe Arkin, Mr. Itai Arkin, Ms. Hani Lerman, Mr. Shmuel Ben Zvi, Ms. Yaffa Krindel-Sieradzki, Mr. Jonathan B. Siegel, Mr. Ran Gottfried and Mr. Jerrold S. Gattegno to the board of directors of the Company, each for an additional one-year term until the annual general meeting to be held in 2023;
4.To approve the annual cash bonus plan for 2022 for Dr. Alon Seri-Levy, the Company's chief executive officer;
5.To approve an amended Compensation Policy for a period of three years.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-04 |
财报披露：
美东时间 2021-08-04 盘前发布财报
|
| 2021-06-01 |
股东大会：
将于2021-07-08召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the year 2021 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2020;
2.To approve the re-election of Mr. Moshe Arkin and Mr. Itai Arkin as Class III directors to the board of directors of the Company (the "Board of Directors"), each for an additional three-year term until the annual general meeting to be held in 2024;
3.To approve the annual cash bonus plan for 2021 for Dr. Alon Seri-Levy, the Company's chief executive officer;
4.To approve an amendment to the Company's Articles of Association to increase the maximum number of directors that may serve on the Board of Directors to ten (10).
|
| 2021-02-18 |
股东大会：
将于2021-03-22召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of each of Mr. Ran Gottfried and Mr. Jerrold S. Gattegno as an external director of the Company, each for a three-year term, subject to, and in accordance with, the provisions of the Israeli Companies Law, 5759-1999, or the Companies Law;
2.To approve the grant of options to purchase ordinary shares of the Company to each of our external directors and other independent directors in accordance with the requirements of the Companies Law;
3.To approve an amendment to the Compensation Policy of the Company.
|
| 2020-05-29 |
股东大会：
将于2020-06-30召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the year 2020 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2019;
2.To approve the re-election of Ms. Hani Lerman and Dr. Alon Seri-Levy as Class II directors to the board of directors of the Company (the "Board of Directors"), each for an additional three-year term until the annual general meeting to be held in 2023;
3.To approve the annual cash bonus plan for 2020 for Dr. Alon Seri-Levy, the Company's chief executive officer;
4.To approve an amendment to the Compensation Policy of the Company.
|
| 2020-03-06 |
股东大会：
将于2020-04-08召开股东大会
会议内容 ▼▲
- 1.To approve a private placement to Arkin Dermatology Ltd., the Company’s controlling shareholder;
2.To approve an amendment to the 2014 Share Incentive Plan to increase the maximum number of ordinary shares of the Company reserved for issuance thereunder by 912,230 ordinary shares.
|
| 2019-05-23 |
股东大会：
将于2019-06-27召开股东大会
会议内容 ▼▲
- 1.To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the year 2019 and for an additional period until the following annual general meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2018;
2.To approve the re-election of Ms. Yaffa Krindel-Sieradzki, Mr. Shmuel Ben Zvi and Mr. Jonathan B. Siegel as Class I directors to the board of directors of the Company (the "Board of Directors"), each for an additional three-year term until the annual general meeting to be held in 2022;
3.To approve compensation for Mr. Jonathan B. Siegel, an independent director of the Company, and for all our future external directors and independent directors in accordance with the requirements of the Companies Law;
4.To approve the annual cash bonus plan for 2019 for Dr. Alon Seri-Levy, the Company's chief executive officer;
5.To approve the redemption of certain accrued but unused vacation days by Dr. Alon Seri-Levy, the Company's chief executive officer.
|
| 2018-04-17 |
股东大会：
将于2018-05-23召开股东大会
会议内容 ▼▲
- 1.To approve the annual cash bonus plan for 2018 for Dr. Alon Seri-Levy, the Company's chief executive officer;
2.To approve the grant of options to purchase Company ordinary shares to Dr. Alon Seri-Levy, the Company’s chief executive officer.
|
| 2018-02-15 |
股东大会：
将于2018-03-22召开股东大会
会议内容 ▼▲
- 1.To ratify the election of each of Mr. Ran Gottfried and Mr. Jerrold S. Gattegno as an external director of the Company, each for a three-year term, subject to, and in accordance with, the provisions of the Israeli Companies Law, 5759-1999, or the Companies Law;
2.To approve the compensation of each of our external directors and our other independent directors, in accordance with the requirements of the Companies Law.
|